EQH vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

EQH

39.4
AI Score
VS
IVZ Wins

IVZ

64.8
AI Score

Investment Advisor Scores

EQH

39score
Recommendation
AVOID NEW MONEY

IVZ

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EQH IVZ Winner
Forward P/E 5.8173 9.5147 EQH
PEG Ratio 0 0.9008 Tie
Revenue Growth -29.8% 20.5% IVZ
Earnings Growth 1244.3% 35.0% EQH
Tradestie Score 39.4/100 64.8/100 IVZ
Profit Margin -8.7% -0.9% IVZ
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD IVZ

Relative Price Performance (Last 90 Days)

EQH 1M: +5.2% · 3M: +13.9% IVZ 1M: -2.6% · 3M: +11.0%

Current Technical Phase

EQH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.3 · Price: $51.95

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.7 · Price: $30.90

Fundamentals Snapshot

Metric EQH IVZ
Market Cap — —
Forward P/E 5.8 9.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 0.1% 0.3%
Operating Margin -0.3% 0.2%
EPS -3.29 -0.68
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.